Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02890368 |
Title | Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Trillium Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope National Medical Center | Duarte | California | 91010 | United States | Details | |
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15237 | United States | Details | |
Inova Schar Cancer Institute | Fairfax | Virginia | 22031 | United States | Details | |
University of Washington - Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |